NURS FPX 4015 Assessment 3: Comprehensive Concept Map Analysis

NURS FPX 4015 Assessment 3

[Student Name]

Capella University

[Prof. Name]

August 2025

NURS FPX 4015 Assessment 3: Concept Map: The 3Ps and Mental Health Care

Major Depressive Disorder (MDD) is a multifaceted and intricate mental health condition that now ranks third globally in terms of disease burden (Bains & Abdijadid, 2023). Often referred to as the “3Ps,” the psychological, physiological, and pharmaceutical components work together to help diagnose, treat, and comprehend major depressive disorder. The concept map helps identify evidence and patient-centered mental health care, and it clarifies key features of the Ivy Jackson case covered in this paper, as demonstrated in NURS FPX 4015 Assessment 3.

Case Scenario

Ivy Jackson, the patient, is a 61-year-old woman who has been depressed for a long time, lost a lot of weight, had trouble sleeping, and is experiencing emotional turmoil following a big life transition. Her symptoms are similar to The criteria for depressive disorder with recurrent major depression are found in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). In order to address her risk factors, diagnostic evaluations, pharmaceutical management, potential consequences, and necessary nursing interventions, NURS FPX 4015 Assessment 3 highlights the necessity of a comprehensive and multidimensional approach.

Mental Health Diagnosis

Ivy fits the diagnostic profile for Major Depressive Disorder (MDD), which is characterized by persistently poor mood, cognitive effort, decreased interest in daily activities, sleep disturbances, and loss of functioning (Bains & Abdijadid, 2023). She denies experiencing regular episodes of hopelessness, anhedonia, and weight loss as a result of her decreased appetite. NURS FPX 4015 Assessment 3 emphasizes that sleeplessness, exhaustion, and difficulty concentrating are additional symptoms. She has no suicidal thoughts, according to a concept map for mental health, but her intense emotional anguish and social disengagement point to a very high-risk level that necessitates careful professional observation.

A recent divorce that has caused emotional instability, a family history of depression, a history of hypertension, and previous depressive episodes are among the risk factors identified by NURS FPX 4015 Assessment 3. Interestingly, Ivy had previously been prescribed venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), but she stopped taking it due to withdrawal symptoms, and her illness returned (Naudin et al., 2022).

According to the mental health concept map, despite the fact that a stressor in her life caused her depressive episode, the length and intensity of her symptoms, as well as neurobiological mechanisms like neurotransmitter imbalance and hypothalamic-pituitary-adrenal axis dysregulation, are more consistent with MDD than with temporary situational depression (Remes, 2021). To address her general well-being, NURS FPX 4015 Assessment 3 suggests evidence-based psychotherapy, lifestyle modifications, and pharmaceutical therapy utilizing escitalopram.

Concept Map: Ivy Jackson’s MDD Risk Factors and Symptoms

Category	Description
Psychological	The mental health nursing concept map emphasizes antisocial behavior, depression, and emotional anguish brought on by divorce. Additionally, the depression gene may show up as a result of a genetic susceptibility inherited from family history.
Physiological	Hypertension and a history of depressive episodes increase vulnerability. Loss of weight and inactivity exacerbate symptoms.
Pharmacological	Venlafaxine discontinuation resulted in relapse, highlighting the fact that pharmaceutical withdrawal and careless transitions might cause relapse.
Signs and Symptoms	Depression, sobbing, difficulty thinking, exhaustion, trouble sleeping, appetite loss, and adverse effects like headaches and nausea.

Diagnostics and Complications

Category	Description
Psychological	The DSM-5’s criteria are used to confirm the diagnosis.
Physiological	A complete blood count, vitamin D, thyroid function, metabolic panel, and other diseases should be ruled out by laboratory tests (Chand & Arif, 2023).
Pharmacological	A review of medication history informs appropriate therapy adjustments.
Complications	Persistent depression, cognitive impairment, increasing hypertension, dietary inadequacies, and relapse due to non-compliance or withdrawal symptoms are among the potential concerns identified by the mental health concept map.

Nursing Diagnoses and Interventions

Category	Description
Psychological	In order to improve emotional stability, therapeutic communication, cognitive behavioral therapy (CBT), and interpersonal therapy (IPT) are used to address problematic coping and dysfunctional social behavior (Lieshout et al., 2022).
Physiological	A mental health nursing concept map will be used to address sleep issues and unhealthy eating patterns. Interventions will include dietary counseling, exercise promotion, and sleep hygiene instruction.
Pharmacological	The best possible treatment outcomes can be achieved by treatment compliance reinforcement, side-effect management, and adherence education.

Conclusion

NURS FPX 4015 Assessment 3 highlights that, after taking into account the interrelated psychological, physiological, and pharmaceutical elements depicted in this concept map, the multifactorial nature of MDD that Ivy Jackson encountered is still complicated. A genuinely holistic plan of care can be provided by nurses by talking about risk factors, diagnostic difficulties, pharmacologic therapy, potential complications, and customized nursing care practices. This kind of integration is used in clinical decision-making and can result in better mental health outcomes and a higher quality of life when done with a mental health concept map.

References

Bains, N., & Abdijadid, S. (2023, April 10). Major depressive disorder. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559078/

Chand, S., & Arif, H. (2023). Depression. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430847/

Lieshout, R. J. V., Layton, H., Savoy, C. D., Haber, E., Feller, A., Biscaro, A., Bieling, P. J., & Ferro, M. A. (2022). Public health nurse-delivered group cognitive behavioral therapy for postpartum depression: A randomized controlled trial. The Canadian Journal of Psychiatry, 67(6), 432–440. https://doi.org/10.1177/07067437221074426

Naudín, M. A.-P., Abejón, E.-G., Gómez, F.-H., Lázaro, D.-F., & Álvarez, F. J. (2022). Non-adherence to antidepressant treatment and related factors in a region of Spain: A population-based registry study. Pharmaceutics,14(12), 2696. https://doi.org/10.3390/pharmaceutics14122696

Remes, O. (2021). Biological, psychological, and social determinants of depression: A review of recent literature. Brain Sciences, 11(12), 1–33. https://doi.org/10.3390/brainsci1